FOLH1 and posterior cortical atrophy: In a recent study by Tamburo et al., data on 33 patients with recurrent PCa demonstrated that PSMA PET/CT-guided salvage RT can achieve good oncological outcomes with a complete clinical response in 70% of the patients 1 year after the treatment [38].